Shares of Fate Therapeutics were up more than 21 percent in trading after the company announced a multi-billion dollar deal with Janssen Biotech to develop cell therapies for the treatment of cancer.
If you are not happy with the results below please do another search
50 search results for:
When COVID-19 first appeared in the news, scientists took note and began to prepare for a widespread outbreak. The general population, however, was not concerned. Many assumed COVID-19 would be like the SARS outbreak.
The U.S. Food and Drug Administration approved the first blood test that looks for the antibodies against the novel coronavirus that causes COVID-19.
A look at some of the more interesting scientific studies recently published, including an analysis of the first U.S. community-transmitted COVID-19 patient that led to updated CDC guidelines.
Novartis and Incyte are launching a Phase III clinical trial to determine if the cancer drug Jakavi (ruxolitinib) can be used to treat COVID-19.
The global scramble to secure face masks to shield frontline workers from the coronavirus has turned the marketplace into the “Wild West”, with the United States often ready to outbid buyers who have already signed deals, European officials say.
People mother and father are truly blessed, you say, or is it that all those children have been taught to be dependable and the rewards are now remaining reaped? It could rely upon the child as you could have guessed. If you are not in that tiny percentage of mothers and fathers, you can, nonetheless, […]
To help local hospitals provide their frontline healthcare professionals with an extra line of defense during COVID-19, Klick Health and Humber River Hospital announced the availability of 300 intubation boxes for Greater Toronto Area (GTA) hospitals in need.
The European Commission approved Pfizer Inc.’s Ruxience (rituximab) – a monoclonal antibody and biosimilar to MabThera – for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis, and pemphigus vulgaris.
The recent 20th anniversary of the groundbreaking “To Err is Human” report that launched the modern patient safety movement is cause for reflection on the healthcare industry’s past and future efforts to reduce medical errors and preventable deaths.